Abrin (ABR) 1 and ricin belong to the type II ribosome inactivating proteins which are heterodimeric glycoproteins that contain a toxophoric A-chain with protein synthesis inhibitory activity and a lectin B-chain that binds to D-galactose moieties on the cell membrane (1) . The A-chain is transferred across the plasma membrane by the B-chain via endocytotic vesicles into cells (2) . In addition to their ability to inhibit protein synthesis, recent studies have shown that these toxins are able to induce apoptosis (3) (4) (5) . Baluna and colleagues (6, 7) have suggested that inhibition of protein synthesis and apoptosis may be mediated by different segments of the ricin A-chain molecule. Besides the inhibition of protein synthesis, it is an attractive hypothesis that ABRA adopts alternative molecular mechanisms to trigger apoptotic programs.
Apoptosis is a form of cell death that leads to elimination of excess or damaged cells. Apoptosis contributes to tissue homeostasis and embryonic development (8) . A range of stimuli including DNA damage, growth factor withdrawal, anticancer drugs, and members of the tumor necrosis factor receptor family of death receptors can induce apoptotic signals (9 -11) . The apoptotic cascade in mammalian cells is a multistep process (12) . In most cases, the apoptotic cascade is initiated by loss of integrity of the outer mitochondrial membrane accompanied by release of cytochrome c from the intermembrane space of mitochondria to cytosol. The cytosolic cytochrome c serves as a cofactor with the apoptotic protease activating factor (Apaf-I) to activate pro-caspase 9 (13) (14) (15) . Caspase-9 then activates other caspases, which undermine the structural integrity of the cells by cleaving a key structural protein substrate (16) .
The signaling events that affect the particular apoptotic mediators are currently a focus of intense study. Reactive oxygen species (ROS) participate in a wide variety of cellular functions, including cell proliferation, differentiation, and apoptosis (17, 18) . Addition of ROS or depletion of cellular antioxidants induces apoptosis (17, 19, 20) , and ROS are likely to act as signaling intermediates that are involved in the signal transduction mechanism for apoptosis (17, (21) (22) (23) .
Elucidation of the mechanism that is involved in ABR-triggered apoptosis is important for the development of cancer chemotherapeutic agents. In order to identify ABRA-interacting proteins, the yeast two-hybrid system was used. Since ABRA inhibits the growth of yeast cells by its N-glycosidase activity, ABRA(E164Q) with a mutation of its N-glycosidase catalytic site was employed.
In this paper, we report on an ABRA(E164Q)-interacting protein, AOP-1, which is an antioxidant protein with two catalytic conserved cysteine residues and has 93.3% identity to SP-22 (24, 36) , a mitochondria antioxidant protein. We show that ABRA can directly inhibit the antioxidant activity of AOP-1 in vitro and two antioxidants N-acetylcysteine (NAC) and 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (4-OHtempo) can delay ABR-induced apoptosis, suggesting that ABR may deplete cellular antioxidants. Moreover, the ectopic expression of AOP-1 prevents both mitochondrial cytochrome c release and phenotypic apoptosis in response to ABR. Taken together, our results support AOP-1 as one of the target molecules of ABRA-induced apoptosis.
EXPERIMENTAL PROCEDURES
Materials-A Matchmaker Two-Hybrid System 2 kit was purchased from CLONTECH (Palo Alto, CA). Restriction endonucleases were obtained from New England Biolabs, Inc. (Beverly, MA). Chemicals for nucleotide autosequence analysis were purchased from PE Applied Biosystems (Foster, CA). Taq DNA polymerase, large scale RNA production system-T7, and rabbit reticulocyte lysate translation system, and the CaspACE assay system were purchased from Promega (Madison, WI). [ 35 S]Methionine was obtained from PerkinElmer Life Sciences. DCFH-DA, Hoechst 33258, N-acetylcysteine, and 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl were purchased from Sigma. Glutathione-Sepharose 4B gel and pGEX-2T were obtained from Amersham Pharmacia Biotech (Uppsala, Sweden). Abrin-a was purified from Abrus precatorius as described (1) . An in situ cell death detection kit was purchased from Roche Molecular Biochemicals GmbH (Mannheim, Germany). The protease inhibitor Cbz-Val-Ala-Asp-(OMe)-fluoromethyl ketone (zVAD-fmk) was purchased from Kamiya Biomedical Co. (Seattle, WA). The fluorescent tetrapeptide protease substrate, Ac-LEHD-AFC, was obtained from Calbiochem (San Diego, CA). Anti-cytochrome c antibodies (7H8.2C12 and 6H2.B4) were from PharMingen (San Diego, CA). Anti-␣-tubulin antibody was purchased from Zymed Laboratories Inc. (San Francisco, CA). Anti-flag M5 antibody was purchased from Eastman Kodak Co. Chicken anti-DYKDDDK (flag) polyclonal antibody, high fluorescent FITC-labeled goat anti-mouse antibody, and rhodamine-conjugated rabbit anti chicken antibody were from Chemicon International (Temecula, CA).
Cell Culture-HeLa cells and 293 T cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 100 units/ml penicillin, and 100 g/ml streptomycin (Life Technologies, Inc.) under 5% CO 2 at 37°C.
Yeast Two-hybrid System-Since wild type ABRA is detrimental to yeast, mutant ABRA(E164Q) cDNA was fused to pAS2-1 vector to screen a Jurkat cDNA library cloned in the pGAD10 vector. A total of 1.2 ϫ 10 6 clones were analyzed, and the transformed yeast was selected on synthetic dropout agar plates lacking leucine, tryptophan, and histidine in the presence of 50 mM 3-amino-1,2,4-triazole (Sigma). Twentyfour colonies that developed color on filter paper were restreaked on selective plates to allow plasmid segregation and tested again for ␤-galactosidase activity. For quantitative data, the liquid culture assay using o-nitrophenyl-␤-D-galactopyranoside as a substrate was performed, and the hydrolysis of the substrate was measured at A 420 . Two clones were specific for ABRA(E164Q). Nucleotide sequence analysis of cDNA inserts was performed using a PE Applied Biosystems automated sequencer.
In Vitro Binding Assay-GST-ABRA(E164Q) fusion protein was expressed in Escherichia coli and purified by affinity chromatography on glutathione-agarose as described (25) . In vitro translated 35 S-labeled AOP-1 was prepared by using pBluescript-AOP-1 as a template with an RNA production system-T7 and rabbit reticulocyte lysate translation system as described by the supplier with modifications. The translation reaction contained 2 mM GTP and 2 mM MgCl 2 in addition to the original formula. For the binding assay, BSA-washed glutathione-agarose beads were bound to GST-ABRA(E164Q) or GST in buffer containing 10 mM Na 2 HPO 4 , 150 mM NaCl, 2.7 mM KCl, 1.8 mM KH 2 PO 4 , 10 mM DTT, and 1% Triton X-100 for 1 h at 4°C and then washed six times with the same buffer. After the GST-or GST-ABRA(E164Q)-bound beads were incubated with 35 S-labeled AOP-1 (50 l of in vitro translated product) for 2 h at 4°C, the reaction products were extensively washed with the same buffer and extracted with SDS sample buffer. The extracts were analyzed by SDS-PAGE and exposed to Kodak x-ray film.
Transfection of HeLa Cells with AOP-1 cDNA-A 768-base pair cDNA containing the entire coding region of AOP-1 and a flag tag at its C terminus was subcloned into a mammalian expression vector, and the plasmid purification was prepared using a Qiagen Maxi Kit (Groningen, Netherlands). HeLa cells were transfected with the mammalian expression vector pcDNA3-AOP-1 using LipofectAMINE reagent according to the manufacturer's instructions. The LipofectAMINE-DNA complexes were left on the cells for 5 h, and then the transfection mixtures were removed and replaced with normal growth medium to grow for 24 h.
Preparation of Subcellular Fractions and Immunoblotting-Cells were washed twice with PBS, and the pellet was suspended in 0.5 ml of buffer containing 20 mM Hepes, pH 7.4, 10 mM KCl, 1.5 mM MgCl 2 , 1 mM EDTA, 1 mM EGTA, 1 mM DTT, protease inhibitors (Complete Mixture, Roche Molecular Biochemicals), and 250 mM sucrose. The cells were homogenized by 40 strokes in a Dounce homogenizer. The homogenates were centrifuged at 500 ϫ g for 10 min at 4°C to remove nuclei and unbroken cells, and the supernatant was re-centrifuged at 8,000 ϫ g for 10 min at 4°C to pellet the crude mitochondria fraction. The supernatant was centrifuged at 20,000 ϫ g for 30 min at 4°C, and the supernatant was referred to as the cytosolic fraction. Samples containing 40 g of protein were subjected to 12% SDS-PAGE and electroblotted on a polyvinylidene difluoride membrane. The membrane was probed with anti-cytochrome c monoclonal antibody 7H8.2C12 at a dilution of 1:1,000, anti-flag M5 antibody at a dilution of 1:1,000, and anti-␣ tubulin antibody at a dilution of 1:2,000 in the buffer followed by horseradish peroxidase-conjugated goat anti-mouse IgG. Antigen-antibody complexes were visualized by enhanced chemiluminescence (Amersham Pharmacia Biotech).
Immunocytochemistry and Confocal Microscopy-HeLa cells were grown on glass coverslips for 24 h in DMEM containing 10% FBS. Cells were transfected with pcDNA3-AOP-1 as described previously. Apoptosis was induced by ABR treatment. The reaction was terminated by washing the culture cells three times with PBS, followed by fixation in freshly prepared 4% paraformaldehyde in PBS for 12 min. The fixed cells were washed three times in PBS, followed by permeabilization in 0.2% Triton X-100 in PBS for 2 min. The cells were then blocked for 30 min in blocking buffer (0.2% Triton X-100 and 10% FBS in PBS), followed by a 1-h incubation with mouse monoclonal antibody against cytochrome c (6H2.B4) at a dilution of 1:1,000 and chicken polyclonal antibody against DYKDDDK(flag) at a dilution of 1:500. The cells were washed four times at 10 min each in blocking buffer followed by a 1-h incubation with a fluorescein-conjugated goat anti-mouse antibody for cytochrome c and a rhodamine-conjugated rabbit anti-chicken antibody for flag. After extensive washing, slides were mounted and examined under a Zeiss Axipophot inverted microscope with a 100ϫ oil objective lens.
To assess colocalization of AOP-1 with ABR in HeLa cells, uptake experiments with ABR and immunofluorescence for detecting endogenous AOP-1 were performed. Cells were incubated in serum-free medium containing 10 g/ml FITC-ABR for 30 min at 4°C and then warmed at 37°C for 45 min. The treated cells were placed back on ice, rinsed with 0.1 M galactose to remove surface-bound FITC-ABR, fixed, permeabilized, and stained for AOP-1 using rabbit polyclonal antibody and a rhodamine-conjugated goat anti-rabbit antibody. Samples were imaged on a confocal laser scanning microscope (Leica TCS SP2), with a 100ϫ oil objective lens.
Assessment of Apoptosis-Apoptotic cell death was examined by the terminal deoxynucleotidyl transferase-catalyzed deoxyuridine triphosphate (dUTP)-nick end labeling (TUNEL) method as described by the supplier (Roche Molecular Biochemicals). Samples (10 4 events) were analyzed with a Becton-Dickinson FACSCalibur, and the distribution of cells was determined.
To assess DNA ladder formation, HeLa cells (1 ϫ 10 6 ) were treated with various concentrations of ABR for 24 h at 37°C. The DNA were digested overnight at 37°C in 0.5 mg/ml proteinase K and 0.5% sarcosyl in PBS, treated with 10 g of RNase A for 1 h at 37°C, then gently extracted with phenol and chloroform, and analyzed on 1.5% agarose gel.
The viability of cells was assessed by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay. Cells were preincubated with NAC or 4-OH-tempo for 2 h ,followed by treatment with 5 ng/ml ABR for 15 h. The medium was replaced by 500 l of MTT solution (1 mg/ml in DMEM supplemented with 10% FBS) and further incubated for 1 h at 37°C. The well was then washed three times with PBS, and ethanol was added to the well. The absorbance at 570 nm was measured by an enzyme-linked immunosorbent assay reader.
Measurement of Intracellular ROS-Levels of intracellular ROS were measured as described (26) with minor modifications. Briefly, HeLa cells (1 ϫ 10 6 /ml) were treated with 100 ng/ml ABR for various periods of time and they were incubated with 10 M DCFH-DA in the dark for 30 min before the cells were harvested. The cells were washed with PBS and analyzed (excitation, 488 nm; emission, 515-540 nm) on a Becton-Dickinson FACSCalibur.
Assay of AOP-1 Antioxidant Activity-The primers, 5Ј-GGGAATTC-CATATGGCACCTGCTGTCACCCAGCATGCA-3Ј and 5Ј-CGGGATC-CCTACTGATTTACCTTCTGAAA-3Ј, were designed to PCR amplify a 585-base pair fragment from pGAD10-AOP-1. The amplified DNA fragment encoding the amino acids 62-256 of AOP-1 was subcloned in-frame to the NdeI/BamHI sites of the bacterial expression vector pET-15b. The expression plasmid was transformed into bacteria BL21(DE3) pLysS, and the recombinant AOP-1 (re-AOP-1) was purified as described by the supplier.
The thiol-specific antioxidant activity of AOP-1 was measured by the method described by Kim et al. (27) with slight modifications. Assays were performed in a 50-l reaction mixture containing 0.5 unit of glutamine synthetase, 10 mM DTT, 12 M FeCl 3 , 100 mM Hepes (pH 7.4), with re-AOP-1 (0.06 mg/ml) and various amounts of ABRA(E164Q) and were incubated at 30°C. At various time periods, aliquots (10 l) were removed to assay the residual glutamine synthetase activity.
Measurement of DEVDase and LEHDase Activities-The CaspACE assay system was used according to the instructions of the manufacturer. Briefly, cytosol extracts (50 g) were incubated with 245 l of reaction buffer containing 80 l of caspase buffer, 5 l of Me 2 SO, and 10 mM DTT for 30 min at 30°C and then Ac-DEVD-AMC or Ac-LEHD-AFC was added at a final concentration of 50 M. The reaction mixtures were incubated for 1 h at 30°C. Cleavage of fluorogenic substrate was quantitated by using a fluorescence spectrophotometer (F-4500, Hitachi) at 360/460 nm or 400/505 nm.
RESULTS

Interaction of AOP-1 with ABRA(E164Q)-
To identify proteins interacting with ABRA, a yeast two-hybrid system was employed. Two clones that specifically interacted with ABRA(E164Q) were confirmed by a colony-lift ␤-galactosidase filter assay and were quantified by a liquid culture assay (Table  I) . Sequencing of these cDNA clones identified two major transcripts, which consisted of an open reading frame encoding 256 amino acids (Fig. 1) . Computer analysis using NCBI/BLASTN (28) revealed that the open reading frame was identical to human protein AOP-1 (24) . Data base searches revealed that AOP-1 shared 93.3% identity with SP-22, a bovine mitochondrial thioredoxin-dependent peroxide reductase, and the N-terminal sequence contained the basic features of mitochondrial targeting signal (29) (Fig. 1) . The mitochondria targeting signal was composed of 20 -60 amino acid residues with abundant positive charges, no negative charges, and frequent hydroxylated residues, and they were rich in hydrophobic residues (30 -32) . The sequence upstream of the cleavage site was coincident with the specificity of two processing peptidases for mitochondrial proteins. The amino acid sequences RX2(F/L/ I)XX(T/S/G)XXXX2 were cleaved sequentially in two steps by mitochondrial processing peptidase and mitochondrial intermediate peptidase (33) . The data showed a high probability that AOP-1 was localized in the mitochondria.
To confirm that AOP-1 did indeed bind to ABRA(E164Q), human AOP-1 was transcribed and translated in vitro. We used GST-ABRA(E164Q) linked to glutathione-Sepharose beads to examine the interactions between ABRA(E164Q) and AOP-1. After incubation with 35 S-labeled AOP-1, these GST-ABRA(E164Q) beads (or the control bait, GST beads) were pelleted and washed extensively. The proteins which remained bound tightly to GST or to GST-ABRA(E164Q) were resolved by SDS-PAGE. The 35 S-labeled AOP-1 was visualized by autoradiography. The AOP-1 protein was bound specifically by the GST-ABRA(E164Q) (Fig. 2) . Taken together, these data suggest that AOP-1 is an ABRA(E164Q)-interacting protein.
AOP-1 Localized in the Mitochondria-To determine whether AOP-1 localizes in the mitochondria as SP-22 does, we examined the localization of AOP-1 within the cells and compared it with the distribution of ␣-tubulin. We constructed a plasmid clone pcDNA3-AOP-1 that was designed to express AOP-1 with a flag tag at the C-terminal end (AOP-1-flag). This plasmid DNA was transfected into HeLa cells, and the distribution of AOP-1-flag was detected by subcellular fractionation and Western blotting. As shown in Fig. 3A , the subcellular localization of AOP-1-flag was found in the mitochondria, and this indicated that AOP-1 was distinctly separated from␣-tubulin. To further confirm the mitochondrial localization of AOP-1, immunofluorescence staining was carried out by using an anti-cytochrome c antibody (a well characterized mitochondria marker). In HeLa cells, the anti-cytochrome c antibody gave a punctate staining pattern characteristic of mitochondrial localization and the AOP-1-flag colocalized with cytochrome c (Fig. 3B) . The same results were obtained by rabbit anti-AOP-1 polyclonal antibody to detect endogenous AOP-1 (data not shown). We conclude that AOP-1 localizes in the mitochondria.
Colocalization of AOP-1 and ABR-The ability of AOP-1 and ABR to associate in vivo would indicate a possible role for this interaction in ABR-induced apoptosis. We studied the intracellular localization of AOP-1 and ABR by confocal microscopy of HeLa cells, which were treated with FITC-conjugated ABR and stained for endogenous AOP-1. In Fig. 4 , green fluorescence indicated the endocytotic FITC-ABR (left panel) and red fluorescence showed the mitochondrial punctate staining of AOP-1 (center panel). As shown in the right panel, there was colocalization of AOP-1 and ABR in yellow (white arrows). The data suggest that ABR interacts with AOP-1 in vivo.
Induction of Apoptosis and Endogenous ROS by ABR-The typical laddering pattern of fragmented DNA associated with apoptosis appeared after exposure of cells to 100 ng/ml ABR (Fig. 5A) . The nuclei of HeLa cells treated with ABR and then stained with Hoechst 33258 showed that chromatin condensation was produced in apoptotic cells (data not shown). These results are consistent with previous studies (34) and show that abrin is able to trigger programmed cell death.
To determine whether the level of ROS in ABR-treated cells was increased, we used FACS analysis with DCFH-DA, which is a nonpolar compound that readily diffuses into cells and is hydrolyzed to DCFH by esterase. When DCFH is oxidized within the cell, it becomes a highly fluorescent 2Ј,7Ј-dichlorofluorescein. The fluorescence of untreated HeLa cells represented the endogenous ROS, and 300 M H 2 O 2 treatment was used as a positive control (Fig. 5B) . The intracellular ROS was increased 2-fold at 4 h after ABR treatment. The results suggest that the level of ROS is increased at the early phase in ABR-treated cells. (51) . b The plasmids pVA3 and pTD1-1 contain murine p53 and SV40 large T-antigen, respectively, which interact strongly and serve as a positive control.
Since increases of ROS generation in ABR-treated cells are the early sign of the ABR toxicity, it is suggested that ROS are important mediators of ABR-induced cell death. To test whether ROS levels play a role in mediating the death signal of ABR, two antioxidants NAC and 4-OH-tempo, which is known to be localized into the mitochondria, were used, and the results showed that the antioxidants inhibited ABR-induced apoptosis in a dose-dependent manner (Fig. 5C) . These data further demonstrate that the generation of ROS plays an important role in the induction of apoptosis by ABR.
ABRA(E164Q) Inhibited the AOP-1 Antioxidant Activity in Vitro-
To further examine whether ROS are important mediators of ABR-induced cell death, we tested the effects of re-ABRA(E164Q) on the antioxidant activity of recombinant AOP-1 in vitro. The antioxidant activity of re-AOP-1 was detected by monitoring the ability of the protein to inhibit the inactivation of glutamine synthetase using a DTT/Fe 3ϩ /O 2 metal-catalyzed oxidation system (27) . Various amounts of ABRA(E164Q) were added to the reaction mixture, and the protection value of AOP-1 (0.06 mg/ml) was decreased from 81% protection (AOP-1 alone) to 32% (molar ratio: AOP-1: ABRA(E164Q) ϭ 1:2; Fig. 6 ). The inhibitory effects of ABRA(E164Q) on AOP-1 antioxidant activity were dose-dependent. The results indicate that ABRA(E164Q) not only specifically interacts with AOP-1, but also directly inhibits the antioxidant activity of AOP-1, which may elevate the level of ROS, followed by cell death.
ABR Induced the Translocation of Mitochondrial Cytochrome c into the Cytosol and the Activation of Caspases-To
study whether the release of cytochrome c from the mitochondria to the cytosol is involved in ABR-triggered apoptosis, the amount of cytochrome c in the cytosol was determined by immunoblot analysis. Untreated cells did not contain any detectable amounts of cytochrome c in the cytosol, whereas the level of cytosolic cytochrome c was increased significantly at 4 h after ABR treatment (Fig. 7A) . The results suggest that ABR induces apoptosis by releasing cytochrome c from the mitochondria to the cytosol. The intracellular distribution of cytochrome c in HeLa cells was further examined by immunofluorescence staining. Treatment of HeLa cells with ABR for 4 h induced the loss of mitochondrial cytochrome c staining (Fig. 7B) . Arrows indicated that cells with ABR treatment have more diffuse cytochrome c immunostaining. These findings indicate that ABR-triggered apoptosis is through the release of cytochrome c.
To assay the role of caspases in ABR-mediated apoptosis, zVAD-fmk, a broad spectrum inhibitor of mammalian caspases, was preincubated with HeLa cells and then the cells were treated with ABR for 24 h. FACS analysis with TUNEL indicated that zVAD-fmk prevented cell death in a dose-dependent manner, and 80 M zVAD-fmk inhibited about 50% of cell death caused by ABR treatment (Fig. 8A) . The results indicate that caspases are involved in ABR-triggered apoptosis.
To assess the involvement of caspase-9 and caspase-3, acti- vation of caspases was evaluated by the cleavage of the fluorogenic substrates, Ac-LEHD-AFC and Ac-DEVD-AMC. After treatment of HeLa cells with ABR for 4 h, caspase-9 and caspase-3 activities were increased to 4-and 10-fold, respectively (Fig. 8, B and C) . Caspase-1 activity was not increased after ABR treatment (data not shown). These results demonstrate that ABR-triggered apoptosis is through the release of cytochrome c and the activation of caspase-9, which in turn activates caspase-3.
AOP-1 Attenuates Apoptosis and Cytochrome c Release-As described above, the antioxidant activity of AOP-1 was inhibited by ABRA in vitro and antioxidants such as NAC and 4-OH-tempo delayed ABR-induced cell death. We examined whether ectopic expressed AOP-1 could attenuate the apoptosis induced by ABR. The anti-apoptotic activity of AOP-1 was assayed by FACS analysis. When HeLa cells were transiently transfected with 3 g of AOP-1 plasmid before the treatment with 100 ng/ml ABR for 24 h, cell death decreased from 79% to 41% (Fig. 9A) . These results suggest that the overexpression of AOP-1 can attenuate ABR-induced apoptotic cell death. To investigate whether the overexpression of AOP-1 is capable of regulating the release of cytochrome c from the mitochondria in ABR-treated cells, we performed Western blot analysis. As shown in Fig. 9B , HeLa cells transfected with various amounts of AOP-1 plasmid were treated with ABR and the release of cytochrome c from the mitochondria was decreased in a dose-dependent manner. The results indicate that overexpression of AOP-1 can inhibit the translocation of cytochrome c from the mitochondria to the cytosol in ABR-treated cells.
To further confirm the inhibitory activity of AOP-1 on the translocation of cytochrome c, immunofluorescence staining of HeLa cells with anti-cytochrome c and anti-AOP-1-flag antibodies was carried out. ABR induced the accumulation of cells with diffuse cytochrome c staining, which was significantly inhibited by AOP-1 (Fig. 9C) . Arrows indicated that non-trans- fected cells with ABR treatment possessed more diffuse cytochrome c immunostaining. In contrast, AOP-1 transfected cells with ABR treatment maintained a punctate cytochrome c immunostaining pattern. These findings demonstrate that AOP-1 maintains cytochrome c within the mitochondria and is an important target molecule in ABR-induced apoptosis.
DISCUSSION
In this report, we have identified a novel ABR-interacting protein, AOP-1, which was originally reported to be a thiolspecific antioxidant protein in vitro (35) , but its physiological function was unclear. Analysis of the amino acid sequence has revealed that the N-terminal 61 amino acids have characteristics of signals that target translocation of proteins into mitochondria. By Western blot analysis and immunocytochemistry (Fig. 3) , we have shown that AOP-1 is located in the mitochondria and not in the cytoplasm. AOP-1 is 93.3% identical (97.4% similar) to SP-22, which has been reported to be one of the antioxidant proteins located in the mitochondria (29) . Both of them conserve the two critical motifs found in all human peroxide reductases (the two cysteine-containing segments Cys 47 (FFYPLDFTFVCPTEI) and Cys 168 (HGEVCPA)). These cysteine motifs have been suggested as being important for the catalysis of peroxides (36, 37) . Proteins imported into the mitochondria are usually cleaved by proteases, thereby losing their N-terminal signal sequence. The resulting recombinant AOP-1 protein showed antioxidant activity (Fig. 6 ). These results suggest that AOP-1 can scavenge ROS as SP-22 does by cooperating with mitochondrial thioredoxin and can protect mitochondrial components from the action of superoxide anions or hydrogen peroxide (38, 39) . It will be interesting to determine whether there are other factors cooperating with AOP-1 to function as an antioxidant complex in the mitochondria.
Mitochondria play a key role in the regulation of apoptosis. The oxidant stress triggers mitochondrial permeability transition pore opening by oxidizing thiol groups in the pore protein (40, 41) . Thus, the mitochondrial redox potential is important for regulating the opening of mitochondrial permeability transition pore, which in turn allows the release of cytochrome c and then induction of caspase-dependent apoptosis (42) (43) (44) . Interestingly, ABR induces cells to generate ROS and the antioxidants NAC and 4-OH-tempo can delay ABR-caused cell death. The overexpression of AOP-1 can attenuate the apoptosis and block the release of cytochrome c in ABR-treated cells (Fig. 9) . These data indicate that AOP-1 functions in the protection of cells from apoptosis and may be implicated as an endogenous regulator of apoptosis.
We have shown that recombinant ABRA(E164Q) inactivates the antioxidant activity of AOP-1 in vitro (Fig. 6) . Hence, we speculate that ABRA interacts with AOP-1 and inactivates the antioxidant activity of AOP-1, which may initiate apoptosis by a pathway distinct from inhibition of protein synthesis. Notably, zVAD-fmk, a broad spectrum caspase inhibitor, was unable to completely abrogate apoptosis caused by ABR. One explanation for this is that the activation of caspase is not the only pathway involved in apoptosis. The stress caused by the inhibition of protein synthesis partially contributes to ABR-triggered apoptosis. It has recently been demonstrated that the segment of the ricin A-chain (SVTLALDVTNAY) linked to antibodies can induce the apoptosis of human vein endothelial cells (7) . The data suggested that the ricin A-chain-mediated inhibition of protein synthesis and apoptosis might be exerted by different motifs of the ricin A-chain molecule.
In summary, we propose the model shown in Fig. 10 . The binding of ABRA(E164Q) to AOP-1 can shield the sulfhydryl groups and result in the inhibition of the antioxidant activity. As a consequence of the loss of AOP-1 antioxidant activity, the mitochondrial redox potential is shifted to a more oxidized state and the mitochondria generate large amounts of ROS and release cytochrome c, which in turn activates caspases to trigger apoptosis.
ABR or immunotoxins have a dose-limiting toxicity in vascular leak syndrome in mammals and humans (45) (46) (47) (48) (49) (50) . Since the antioxidants NAC and 4-OH-tempo significantly delay the apoptosis induced by ABR, it is suggested that antioxidants can be employed in reducing the toxicity of immunotoxins and hence improve the efficiency of cancer chemotherapy.
